-
If you purchased shares of Merge Healthcare Inc. (NASDAQ:MRGE) and currently hold any of those NASDAQ:MRGE shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
August 4, 2015 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Merge Healthcare Inc. (NASDAQ:MRGE), was launched concerning whether the takeover of Merge Healthcare Inc. by IBM for $7.13 per share is unfair to NASDAQ:MRGE stockholders.
The investigation by a law firm concerns whether certain officers and directors of Merge Healthcare Inc. breached their fiduciary duties owed to NASDAQ:MRGE investors in connection with the proposed acquisition.
Chicago, IL based Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images. On August 6, 2015, IBM (NYSE: IBM) and Merge Healthcare Inc. (NASDAQ:MRGE) announced the signing of a merger agreement pursuant to which IBM will acquire Merge Healthcare Inc. (NASDAQ:MRGE. Under terms of the transaction, Merge shareholders would receive $7.13 per share in cash, for a total transaction value of $1 billion.
However, the investigation concerns whether the offer is unfair to NASDAQ:MRGE stockholders. More specifically, the investigation concerns whether the Merge Healthcare Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
